6YSQ
| The hC4Nb8 complement inhibitory nanobody in complex with C4b | Descriptor: | Complement C4 beta chain, Complement C4 gamma chain, Complement C4-A alpha chain, ... | Authors: | Zarantonello, A, Laursen, N.S, Andersen, G.R. | Deposit date: | 2020-04-23 | Release date: | 2020-06-24 | Last modified: | 2024-10-09 | Method: | X-RAY DIFFRACTION (3.3 Å) | Cite: | An Ultrahigh-Affinity Complement C4b-Specific Nanobody Inhibits In Vivo Assembly of the Classical Pathway Proconvertase. J Immunol., 205, 2020
|
|
7Q5Z
| |
7Q1Y
| X-ray structure of human A2ML1 | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Alpha-2-macroglobulin-like protein 1, ... | Authors: | Andersen, G.R, Zarantonello, A, Enghild, J.J, Nielsen, N.S. | Deposit date: | 2021-10-22 | Release date: | 2022-04-20 | Last modified: | 2024-05-01 | Method: | X-RAY DIFFRACTION (4.4 Å) | Cite: | Cryo-EM structures of human A2ML1 elucidate the protease-inhibitory mechanism of the A2M family. Nat Commun, 13, 2022
|
|
7Q60
| |
7Q62
| |
7Q61
| Structure of TEV conjugated A2ML1 (A2ML1-TC) | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Alpha-2-macroglobulin-like protein 1 | Authors: | Nielsen, N.S, Zarantonello, A, Andersen, G.R. | Deposit date: | 2021-11-05 | Release date: | 2022-04-20 | Last modified: | 2024-10-09 | Method: | ELECTRON MICROSCOPY (2.88 Å) | Cite: | Cryo-EM structures of human A2ML1 elucidate the protease-inhibitory mechanism of the A2M family. Nat Commun, 13, 2022
|
|
6XZU
| |
6Z6V
| Globular head of C1q in complex with the nanobody C1qNb75 | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, ... | Authors: | Laursen, N.S, Andersen, G.R. | Deposit date: | 2020-05-29 | Release date: | 2020-06-10 | Last modified: | 2024-01-24 | Method: | X-RAY DIFFRACTION (2.19 Å) | Cite: | Functional and Structural Characterization of a Potent C1q Inhibitor Targeting the Classical Pathway of the Complement System. Front Immunol, 11, 2020
|
|